GTU to conduct Examination for final year students, here’s how it will be conducted…!

GTU – Gujarat Technological University to conduct online as well as offline exams on 2nd of July. V.C. of GTU Navin Seth and V.C. of MS University Parimal Vyas raised an issue about exams and said that:

“All private universities are conducting examinations and if state universities do not conduct exams, the students enrolled with them are going to face serious repercussions for the same – in terms of not being able to go for higher study, or even bag a job. “Their competence in the time to come will be challenged.”

So, the GTU has decided to conduct examination for final year candidates.

GTU (@GTUoffice) | Twitter

“Allow universities to frame examination guidelines as per their requirement and local dynamics. The new proposed guidelines may create further issues, so the framework of new guidelines regarding cancellation of examination must incorporate the flexibility of giving autonomy to individual universities for taking the decision regarding the date, mode of examination and other related guidelines in line with the set norms of UGC,” – the V.C. said.
GTU also plans to conducts for those who have fear and lives in containment zone via online mode as well as off in the month of September-October.
We have students from 32 states. To bring uniformity in exam patterns for Gujarat, out of state and of India students, we decided to conduct online exams for all. I raised only one point and asked All India University members that they should convey to UGC that universities should be given autonomy to decide and conduct exams. No mandatory guidelines for all universities should be set for blanket implementation,” Vyas said
GTU gets 'Most Trusted State University' - Times of India
The online mode of exam will be conducted with high safety in hand on hand with varasity, and planned to conduct exams of around 1600+ students with 1 supervisor for each 15 student and the computers will be completely checked there will be no copy-paste option available as well as browsing on the internet will also be disabled for an additional security each and every 1600+ students movement will be recorded, computers will be properly sanitized before and after use.
The offline exams will be conducted for those who are willing to go for offline mode. There will only 15 students on each class and 1 supervisor for each 15 students proper distance will be allotted between each student and proper sanitation procedure will be followed up.
The timings of the online mode is 2.5 hours where as for offline mode is 2 hours with the reduced question. For different typing speed of each student differs additional half hour time is allotted for students of online mode of examination.
GTU diploma, PDDC and BPH December 2018 exam result declared at ...

What Should Parents Know About COVID-19-Related Anxiety in Kids?

The coronavirus pandemic has disrupted the lives of everyone, including children. Vermont’s mental health professionals have seen higher-than-normal numbers of kids experiencing anxiety brought on by the “Stay Home, Stay Safe” order, school closures, canceled extracurricular activities, and curtailed visits with family and friends.

Thankfully, parents can play an active role in reducing their kids’ anxiety, beginning by reassuring them that they live in a very safe place. According to the Vermont Department of Health, the number of youth under the age of 20 who have contracted COVID-19 remains low, and no Vermont children or teens have died from the virus.

Still, if children seem unusually anxious for a prolonged period, there are things parents can do to help. Dr. Lewis First, chief of pediatrics at the University of Vermont Children’s Hospital, shares his expert advice for managing anxiety in kids.

KIDS VT: What is anxiety?

DR. LEWIS FIRST: Anxiety is a normal emotion we all experience at one point or another as part of our natural fight-or-flight response. Having a little stress or anxiety about something new, different or challenging is normal and prepares us to be sharper and more alert to respond. For a child, it may be a big test or athletic competition. But anxiety can become a problem when a child faces a sudden, prolonged crisis — which makes COVID-19 the perfect scenario for causing stress and anxiety. While their stress may not indicate a classic anxiety disorder, it can reach the upper limits of what a child is emotionally able to handle.

KVT: What signs should parents watch for?

LF: Anxiety becomes a concern when a child experiences a persistence of symptoms associated with this condition. Kids may have physiological complaints such as headaches, stomachaches or loss of appetite. Some kids become irritable or agitated. They may become restless, easily fatigued, have trouble concentrating or difficulty sleeping. Some become disruptive or even withdraw from their parents as a way to cope.

KVT: Does anxiety look different depending upon the child’s age?

LF: Kids of all ages, even babies, can show signs of stress or anxiety, which they can sense from their parents’ unease or experience when they’re around people they don’t know. Babies, toddlers and preschoolers may seem clingier, cry more, get upset easily and not want to do things that they previously enjoyed. Older schoolchildren and early adolescents may exhibit more negativity. They may complain of shortness of breath, shakiness, clamminess, a racing heart and feelings of doom, which are all classic signs of a panic attack.

KVT: When should parents be concerned about a child’s anxiety?

LF: First, parents should realize that the vast majority of children who are showing signs of stress right now are not having classic anxiety disorders. To make such a diagnosis, we need to see at least one sign of excessive anxiety occurring more days than not for at least six months, and we haven’t been dealing with COVID-19 for that long yet.

KVT: What can parents do to help?

LF: Kids tend to stress when they sense that their parents are worried. I know it’s hard right now, but parents need to remain calm and manage their own stress as best they can. This is a great opportunity for families to recognize that, even while isolated or as we slowly get out in public more often, this is a special time together. Parents should build in time to be with their child where it’s not about talking at them but really listening to them. With an older child or teenager, sometimes a parent expressing their own concerns will open the door to them feeling it’s OK to vent their own feelings. Parents can ask a child if there’s something they saw or heard about the coronavirus that worries them, then educate them about what is fact versus fiction. Parents can also reassure their children that scientists and medical professionals around the world are working every day to find new medicines and vaccines that will make this virus go away.

KVT: What can kids do themselves?

LF: Children can be made to feel like they’re part of the solution by practicing physical distancing, good handwashing hygiene and staying home when necessary. Parents should focus on all the positive things their kids are doing. Limit children’s exposure to the news or, with an older child, watch it together as a family so that you can discuss what’s going on. One of the most important things you can do to reduce anxiety is create predictability. Uncertainty breeds anxiety and fear, so parents should create a schedule that is predictable yet flexible and includes plenty of group playtime. Communicate with family, friends, teachers and coaches by phone or videoconference. And parents should not loosen the rules too much on healthy behaviors such as consistent bedtimes, good diet and daily exercise.

KVT: What if kids are still struggling with daily anxiety?

LF: If children just aren’t sleeping well most or all nights, are anxious most of the time, or continue to show the signs and symptoms we’ve discussed, then it’s time to talk to a health care professional. They can recommend treatments such as cognitive-behavioral therapy and even medication. A counselor or therapist can be very helpful in teaching a child coping mechanisms such as taking slow, deep breaths; counting backward from 100; and having a safe space to go to in their minds and/or in their homes. Increased anxiety in adults can lead to physical or emotional abuse, so parents need to manage their own stress levels, too.

© 2020 Kids VT

Maharashtra, Delhi, amongst five states to receive the first batch of COVID-19 drug

Hetero Drug Limited, which is one of India’s leading pharmaceutical companies, has the approval to manufacture and market the generic version of the experimental COVID-19 drug Remdesivir. The company has sent 20,000 vials to five states which include Maharashtra and Delhi.

Both Maharashtra and Delhi happen to be the worst affected states when it comes to the coronavirus. Gujarat and Tamil Nadu are the other two states that will receive the first batch of the drug. The drug Remdesivir is being marketed under the brand name COVIFOR in India.

The capital of Hyderabad, Telangana, where the company is based, will also receive the first batch of the drug. The next batch of the drug is to be shipped to Kolkata, Indore, Bhopal, Lucknow, Patna, Bhubaneshwar, Ranchi, Vijayawada, Kochi, Trivandrum and Goa.

According to the pharmaceutical company, a 100-milligram vial of the drug will cost ₹5,400. The recommended dose for both adults and the paediatric patients are said to be 200 mg on day one followed by a maintenance dose of 100 mg for five days.

At the moment, the drug is being manufactured at the company’s formulation facility in Hyderabad. The active pharmaceutical ingredient (API) is being made in the firm’s Visakhapatnam facility, as per reports by a news agency.

The DCGI had earlier approved the generic versions made by Cipla and Hetero for emergency use in severe cases of coronavirus. The treatment was the first to show results in trials conducted on patients suffering from the disease. It has won approval for emergency use in patients from the US, South Korea and has further received full approval in Japan.

Maharashtra, which is the worst affected state in the country because of the pandemic can, therefore, use this drug to treat critically ill patients. The state currently has 1,47,738 cases of coronavirus with 70,878 cases in Mumbai only.

WHO : Astrazeneca leading in Covid-19 vaccine race, Moderna not far behind

The WHO is in talks with multiple Chinese manufacturers, including Sinovac, on potential vaccines

syringe and pills on blue background
Photo by Anna Shvets on Pexels.com

AstraZeneca’s experimental Covid-19 vaccine is probably the world’s leading candidate and most advanced in terms of development, the World Health Organization’s (WHO) chief scientist said on Friday.

The British drugmaker has already begun large-scale, mid-stage human trials of the vaccine, which was developed by researchers at University of Oxford.

This week, AstraZeneca signed its tenth supply-and-manufacturing deal.

“Certainly in terms of how advanced they are, the stage at which they are, they are I think probably the leading candidate,” WHO chief scientist Soumya Swaminathan told a news conference.

“So it’s possible they will have results quite early.”

Swaminathan said Moderna’s Covid-19 vaccine candidate was “not far behind” AstraZeneca’s, among more than 200 candidates, 15 of which have entered clinical trials.

ALSO READ: Coronavirus LIVE: Vaccine tests need over $30 bn in 12 months, says WHO

“We do know that Moderna’s vaccine is also going to go into phase three clinical trials, probably from the middle of July, and so that vaccine candidate is not far behind,” she said.

“But I think AstraZeneca certainly has a more global scope at the moment in terms of where they are doing and planning their vaccine trials.”

The WHO is in talks with multiple Chinese manufacturers, including Sinovac, on potential vaccines, as well as with Indian researchers, Swaminathan said.

She called for drugmakers to consider collaborating on Covid-19 vaccine trials, similar to the WHO’s ongoing Solidarity trial for drugs. A WHO-led coalition fighting the pandemic on Friday asked government and private sector donors to help raise $31.3 billion in the next 12 months to develop and deliver tests, treatments and vaccines for the disease. The initiative is called the ACT-Accelerator.

Andrew Witty, Special Envoy for the ACT-Accelerator, said it was important to consider a “portfolio of research efforts” for vaccines.

“It’s still very early days in this journey, we may be super lucky – which would be terrific – and have an early win,” Witty said. “Even if it takes 12 to 18 months that would be without precedent, the world’s fast development of vaccine.”